A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma

A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma

BackgroundNicotinamide adenine dinucleotide (NAD+) metabolism is involved in a series of cancer pathogenesis processes, and is considered a promising therapeutic target for cancer treatment. However, a comprehensive analysis of NAD+ metabolism events on immune regulation and cancer survival has not...

Full description

Bibliographic Details
Main Authors: Cheng Jiang, Yujie Zhou, Lizhao Yan, Jianglin Zheng, Xuan Wang, Junjun Li, Xiaobing Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Oncology
Subjects:
glioma
NAD+ metabolism
prognosis
immune checkpoint inhibitor
signature
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1051641/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1051641/full

Similar Items